Background: Symptoms of intermittent claudication (IC) are improved by exercise. The improvement might be secondary to increased blood perfusion or increased muscle mitochondrial capacity. Ischemia followed by reperfusion, also named preconditioning, is known to stimulate the mitochondria. We focused on a calf raise exercise inducing preconditioning in the calf muscle of patients with IC. We hypothesized that 8 weeks of this exercise would increase walking performance and mitochondrial capacity without a change in blood flow.
Patients with intermittent claudication (IC) experience muscle ischemia during walking that is felt as cramping and aching in the affected muscle. 1 The prevalence of IC increases with age, and the number of patients with IC can be expected to increase further as the population of Europe and North America is aging. 2, 3 Thereby, IC will lead to an increased burden for health care systems in the years to come. Patients with IC can benefit from exercise training, besides medical treatment, smoking cessation, and interventions. 4 Supervised exercise programs are efficient, but the number of patients with IC makes it difficult to offer this type of training to everybody. Structured home-based exercise programs also improve walking performance but are less efficient. 5, 6 To meet future demands, efficient and manageable home-based exercise programs are needed. A hallmark of IC is ischemia due to reduced blood flow. Research also supports that patients with IC have reduced enzyme activity and respiratory defects in the muscle mitochondria. [7] [8] [9] Patients with IC seem to increase mitochondrial capacity after exercise training without increasing blood flow. 10, 11 Exercise training to onset of ischemia is recommended for maximal effect in these patients. 1, 12 Such training-induced ischemia followed by reperfusion provokes preconditioning, which improves mitochondrial capacity in both skeletal muscle and heart muscle. 13, 14 The aim of this study was therefore to test whether exposure to a single episode of instruction for daily training without supervision using preconditioning could improve walking performance and mitochondrial capacity in patients with IC, without increasing blood flow.
METHODS

Patient screening
A total of 29 peripheral arterial disease (PAD) patients limited by IC were enrolled in this study. The patients were recruited between February 2015 and January 2016 at the Department of Vascular Surgery, St Olavs University Hospital, Trondheim, Norway. All experimental protocols and procedures were approved by the Regional Committee of Medical and Health Research Ethics, Central Norway (No. 2011/2533), and conformed to the Declaration of Helsinki. Written informed consent was obtained from all participants.
All patients had a physical examination and medical history during the baseline visit and were classified by the following criteria: history of IC; exercise tolerance limited by IC during a screening treadmill test; and anklebrachial index at rest >0.4 and <0. 9 . No age restrictions were applied. Vascular interventions >3 months independent of indication (also critical limb ischemia) but resulting in stable IC symptoms were of no hindrance.
Patients with the following were excluded: absence of PAD; asymptomatic PAD; critical limb ischemia, defined as those with ankle-brachial index <0.4 combined with rest pain or ischemic ulcer; exercise tolerance limited by factors other than claudication (eg, coronary artery disease, dyspnea); vascular interventions in the last 3 months; use of antiplatelet drug other than acetylsalicylic acid (eg, clopidogrel, dipyridamole); use of anticoagulants (eg, warfarin); diabetes mellitus; active cancer; and renal or liver disease that needed treatment or follow-up.
Procedures
Patients were evaluated during study visits at baseline and after 8 weeks of the exercise intervention. During each visit, patients completed tests in the following order: (1) physical examination including a review of current medication; (2) questionnaires on quality of life and physical function; (3) collection of muscle biopsy specimens; (4) exercise and physical function test; and (5) peripheral hemodynamics tests. During the baseline visit, it was determined whether patients could comply with the exercise interventions and perform cardiopulmonary testing.
At the end of the baseline visit, participants were randomized (Fig) between a calf raise exercise group (n ¼ 14) and a walking exercise group (n ¼ 15). An Internet-based randomization database using a 1:1 allocation, offered by the Unit for Applied Clinical Research at our medical faculty, was used. Assessors were blinded to the allocation of each participant.
There were no complications as a result of the exercise interventions. Two patients were excluded from analysis in the walking group; one patient suffered a partial gastrocnemius muscle rupture on the day after the baseline testing, and one patient developed critical ischemia and needed surgery.
Exercise interventions
The calf raise exercise group was instructed to perform calf raise exercise three times a day. Calf raise exercise consisted of the subject's standing in front of a wall, which was used for support of balance. The body was lifted using the calf muscles to the maximal height that the subject could achieve. This was repeated until pain was felt in the calf musculature. After initiation of pain, the subject was instructed to perform five extra calf raises. The five extra calf raises secured ischemia followed by reperfusion of the muscle at rest, thereby establishing a preconditioning situation. The exercise training was entitled "Five plus."
The walking exercise group was instructed to walk near the pain threshold for 30 minutes, three times a week.
Both training regimens were home based and without supervision for 8 weeks. No instructions were given on risk factor management or lifestyle modification to any of the participants. It is normal practice at the vascular clinic that instruction in exercise is provided only once to patients, and it was the intent of the current study to reproduce this practice. We were mainly interested in the improvements after one single instruction of exercise and not the effect of different types of exercise, which would have needed supervision to guarantee adherence.
Adherence
An activity monitor (Vivofit; Garmin, Olathe, Kan) was placed on the arm, which was worn for the whole study period. This was done to monitor compliance. Furthermore, a training diary was given to the participants. The calf raise group registered the amount of calf raises performed during each session. The walking group registered the time and content of each activity. Participants in both groups registered each evening the total counts of activity registered by the monitor. Comparison of the average counts of activity per day in the first week was made to the average counts of the last week. Adherence was based on whether participants followed the instruction of exercise.
ARTICLE HIGHLIGHTS
Measurements
Walking performance and oxygen uptake. Six-minute walk test. A standardized protocol was followed. 15 The self-paced 6-minute walk test assessed the pain-free walking distance as the distance at which participants first reported pain and the distance covered during 6 minutes. Maximal walking distance was the distance at which participants stopped because of claudication pain.
Cardiopulmonary exercise testing. A treadmill (Woodway, Waukesha, Wisc) with a graded GardnerSkinner protocol consisting of a constant speed of 3.2 km h À1 was used for cardiopulmonary testing together with the device MetaMax II and the MetaSoft software (Cortex, Leipzig, Germany). 16 The inclination started at 0%
and increased by 2% every second minute until the end of the test. Peak oxygen uptake (VO 2 peak ¼ mL/kg/min) was determined as being the highest value obtained. Claudication onset time was the onset of claudication pain and peak walking time was the time at which participants stopped the test during the tests on the treadmill. Peripheral hemodynamics. Ankle-brachial index. Ankle-brachial index, an evaluation of blood pressures in the arm and the ankle, was performed at rest. 17 Plethysmography. Plethysmography assessments were conducted as previously described. 18 The blood flow in the lower extremity was assessed with straingauge plethysmography (AI6; Hokanson, Bellevue, Wash).
To assess maximal hyperemic response to ischemia (mL/100 mL/min) to the calf, the thigh cuff was inflated to 220 mm Hg for 5 minutes, resulting in total arterial and venous occlusion of the leg. During the last minute of arterial occlusion, the ankle cuff was inflated to 250 mm Hg. The thigh cuff was deflated to initiate reactive hyperemia. A series of 10 to 15 measurements was performed; during each measurement, the thigh cuff was again inflated for 10 seconds at 40 mm Hg to block the venous reflux. Thereby, the arterial inflow to the calves was measured at rest and as a maximal response in the hyperemic phase.
Mitochondrial function. Muscle biopsy. Biopsy specimens were collected from the lateral part of the gastrocnemius muscle. A microbiopsy technique was conducted to obtain muscle tissue as previously described.
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Permeabilized skeletal muscle fiber preparation. The muscle tissue was treated to permeabilize the extracellular membranes of the muscle fibers, leaving intracellular membranes of the mitochondria intact. 20, 21 The wet weight of muscle fibers (1-3 mg) was measured on a microbalance (Sartorius ME235P-SD; Sartorius AG, Göttingen, Germany) immediately before assessment of mitochondrial respiration.
Mitochondrial respirometry. The muscle fibers were analyzed by high-resolution respirometry measurements (Oxygraph-2k; Oroboros Instruments, Innsbruck, Austria). The oxygen concentration and oxygen consumption were continuously recorded in the chamber. Oxygen consumption per second, per milligram of wet weight of muscle fibers, was addressed as mitochondrial respiration (pmol O 2 /s/mg wet weight of muscle fibers). Measurements were performed at 37 C. All experiments were carried out in hyperoxygenated chambers (250-500 mM oxygen). The substrate, uncoupler, and inhibitor titration (SUIT) protocol was used to examine different branches of the electron transfer system as previously described. [20] [21] [22] This was achieved by adding inductive or blocking substrates to the chamber. All respirometric analyses were made in duplicate. The LEAK state (presented with subscript L ) represents the resting mitochondrial respiration of an unaltered and intact electron transport system in the absence of adenosine diphosphate (ADP). The LEAK state is measured from the electron flow through complex I (CI) and electrontransferring flavoprotein (ETF). Convergent electron flow into the Q-junction from both complex I (CI) and ETF (ETF þ CI) L was induced with the addition of octanoylcarnitine (0.2 mM) and malate (2 mM). OXPHOS state (presented with subscript P ) represents maximal electron flow through the electron transfer system in the presence of ADP. Electron-transferring flavoprotein capacity (ETF þ CI) P was determined following the addition of ADP (5 mM). Mitochondrial respiration specific to complex I (CI þ ETF) P was induced by the addition of glutamate (10 mM). Respiration supported by complex I and complex II (CI þ CII þ ETF) P was then induced with the addition of 10 mM succinate (CI þ CII þ ETF) P . 21 Electron transfer system (presented with subscript E ) state represents the electron transport through the electron transfer system, when it is uncoupled from adenosinetriphosphatase (complex V). Electron transfer system capacity (CI þ CII þ ETF) E was assessed through titration of the proton ionophore carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP; 0.5 M stepwise titration to optimum concentrations ranging from 1.5 to 3 M). Rotenone (0.5 M) was added to inhibit complex I; thereby, electron flow specific to complex II (CII) E can be measured. Finally, malonic acid (5 mM) and antimycin A (2.5 M) were added.
Citrate synthase activity (mitochondrial content). Citrate synthase activity is a biomarker that is representative for the total concentration/volume-density of the mitochondria present in the muscle tissue. 23 Citrate synthase activity was assayed as previously described in homogenates of the permeabilized fibers used in the respiration measurements.
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Health-related quality of life. 36-Item Short Form Health Survey (SF-36). Self-reported physical function was assessed with SF-36, consisting of eight subscales: physical function, physical role, bodily pain, general health, vitality, social function, emotional role, and mental health.
Claudication Scale (CLAU-S). Self-reported walking ability, specific for patients with IC, was assessed with CLAU-S, consisting of five subscales: daily life, pain, social life, disease-specific anxiety, and psychological well-being.
The scores of the SF-36 and CLAU-S were notified separately. Both SF-36 and CLAU-S are validated instruments.
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Statistical analyses
The primary analysis was based on an intention-to-treat basis. Primary end points were maximal walking distance, peak walking time, and mitochondrial respiration supported by electron transfer flavoprotein and complex I. Secondary end points were citrate synthase activity, maximal hyperemic response to ischemia, peak oxygen uptake, and quality of life (CLAU-S and SF-36).
The sample size was based on maximal walking distance and peak walking time data from previous studies 5, 12 and unpublished data, from our group, on improvements in mitochondrial respiration after exercise in older adults. A two-sided significance level of .05 and a power of the test of 80% indicated a need of 14 participants to be included in each group. The primary objective of this study was to compare changes within each group (before vs after). Comparisons within the groups before and after exercise were done using paired t-test. The randomization procedure was used to secure similar baseline characteristics. Continuous data were reported as the mean with standard deviation or as the mean with the standard error of the mean. Significance was considered at P value < .05. All analyses were performed using Stata 13 (StataCorp LP, College Station, Tex).
RESULTS
Demographics. The randomization resulted in similar baseline clinical characteristics between the calf raise group and the walking group (Table I ), except that the calf raise group was heavier than the walking group.
Walking performance. The groups were similar at baseline on each measure of walking performance, except that the calf raise group had a shorter pain-free walking distance. The calf raise group increased (Table II) pain-free walking distance (P ¼ .04), maximal walking distance (P ¼ .047), claudication onset time (P ¼ .02), and peak walking time (P ¼ .01). No changes in walking performance were found in the walking group.
Adherence. Adherence to the instruction of exercise was 100% in the calf raise group and 80% in the walking group. The calf raise group maintained physical activity. A reduction in activity (P < .01) was found in the walking group (Table II) .
Oxygen uptake and peripheral hemodynamics. The groups were similar (Table III) at baseline on oxygen uptake, ankle-brachial index, and maximal hyperemic response to ischemia. Neither group had any significant change in these measures.
Mitochondrial function. The groups were similar at baseline on each measure of mitochondrial function. Mitochondrial respiration did not change within any group (Table IV) . Citrate synthase activity increased (P ¼ .02) significantly within the calf raise group.
Health-related quality of life. The groups were similar at baseline on each measure of quality of life (Tables V  and VI) . The calf raise group increased the subscale disease anxiety (P < .01), meaning that they experienced less anxiety.
DISCUSSION
Calf raise exercise with five extra repetitions, entitled "Five plus," during a period of 8 weeks improved walking performance, measured as maximal walking distance and peak walking time on a treadmill. Calf raise exercise increased citrate synthase activity, a biomarker of muscle mitochondrial volume-density, without changing mitochondrial respiration and maximal hyperemic response to ischemia in patients with IC. No significant changes in walking performance, mitochondrial respiration, volume-density, and blood flow were observed in the walking group. Up to 20% of patients with PAD experience symptoms of IC. 2 The reduced walking performance in these patients results in reduced quality of life. 25 Patients with IC have a 2.5-fold increase in cardiovascular morbidity and mortality compared with an agematched population. 1 Exercise training has been shown to improve walking performance in patients with IC and to reduce cardiac risk and mortality. 12, 26 Supervised training programs are lacking in Europe and North America, even though supervised exercise is cost-effective. [26] [27] [28] The programs seem not to be feasible because of the number of individuals having IC. Some home-based exercise programs have been shown to increase walking performance, whereas others do not. 5, 6, 24 Walking advice alone has been compared with home-based structured exercise, and the latter has shown better results. 5, 6 We propose a new home-based calf raise exercise training focusing on the metabolism in the leg muscles of interest, thereby excluding such classical training goals as cardiopulmonary function but trying to improve the mitochondrial metabolism through preconditioning. The training concept is easy to perform and self-regulatory because the instruction to perform five extra calf raises after debut of pain will remain unchanged with any improvement. It is of value that an exercise program without supervision is followed. Other home-based exercise programs showed an adherence of approximately 80%. 5, 6 Contrary to this, all the participants in the calf raise group adhered to the given instruction. Furthermore, the average age was higher and the anklebrachial index was lower in our calf raise group compared with the home-based studies. This supports that our calf raise exercise has an impact also in older individuals and in those who have more severe PAD. However, this study is not able to clarify whether the response differs in different age groups and different degrees of IC. The calf raise group had improvements in claudication onset time and peak walking time after 8 weeks similar to those of the other home-based programs. 5, 6 Claudication onset time and peak walking time are assessed on a treadmill with increased inclination during testing. Strength training programs [29] [30] [31] have shown similar improvements in walking performance as measured by treadmill. One can speculate whether calf raise exercise strengthens the leg muscle and thereby increases walking performance at steeper grounds. The walking group did not increase claudication onset time and peak walking time after 8 weeks. The structured homebased exercise programs consisted of walking exercise and showed increases in these variables. The difference from our walking group was that participants were contacted several times by the investigators to control whether they adhered to the walking exercise. The calf raise group did not increase activity, which is in line with the other home-based studies. 5 The walking group decreased their activity, which shows that instruction of walking exercise alone is not sufficient to maintain activity and that external control is needed. The pathophysiologic process of IC is mainly explained as a result of the reduced blood flow. A meta-analysis could not find any increase in blood flow after exercise training. 32 This is in accordance with our observations, with no significant changes in blood flow in either group. In patients with IC, besides reduced blood flow, metabolic changes in the muscle mitochondria also occur, expressed as lower mitochondrial enzyme activity. 7, 8, 33 A more effective use by the mitochondria of the oxygen that is delivered to the muscle might therefore be an alternative explanation to the improvement after exercise. 34 Exercise training of healthy elderly with normal blood flow increases muscle mitochondrial capacity. 35 Less is known about mitochondrial adaptations after exercise in patients with reduced blood flow.
We assessed mitochondrial respiration, being a functional assay of mitochondrial oxygen consumption of the complexes collectively during oxidative phosphorylation. This includes a direct analysis of complexes I to IV. We did not find any increase in mitochondrial respiration. After dynamic leg exercise of patients with IC, mitochondrial enzymes that indirectly reflect complex II (succinic oxidase activity) and complex IV function (cytochrome-c oxidase) 1, 11 have been shown to increase.
The only mitochondrial enzyme assessed in this study was citrate synthase activity, which was increased significantly in the calf raise group but not in the walking group. Increased citrate synthase activity has previously been shown after exercise of strength in patients relatively and directly. 10, 36 Our calf raise could therefore be characterized as an exercise of strength, possibly resulting in increased mitochondrial content. Others did not find changes in citrate synthase after walking exercise. 37 Walking exercise focuses on endurance, thereby possibly leading to increased mitochondrial efficiency of the mitochondria present and not leading to increased mitochondrial content. The 6-minute walking distance did not change, indicating that walking speed remained the same. Walking speed has been shown to correlate with mitochondrial adenosine triphosphate production. 35 The lack of change in mitochondrial respiration in our groups might mirror similar mitochondrial energy production per time unit, resulting in unchanged walking speed. The increased mitochondrial content in the calf raise group might improve energy production over time, resulting in an increased maximal walking distance and peak walking time at a similar walking speed. Further research is necessary to clarify the importance of endurance and strength exercise in patients with IC and the resulting mitochondrial responses. Regarding quality of life, a significant change in disease-specific anxiety was found in the calf raise group. This supports the psychological value of home-based, self-regulated training.
Limitations. This is a small study that requires replication in external sites with larger numbers and longer follow-up to determine the external validity of the findings. The calf raise group was heavier at baseline, and they had a lower pain-free walking distance and claudication onset time. These patients might have been deconditioned and thereby had more to gain from exercise. Mitochondrial respiration was assessed under hyperoxygenated conditions. Mitochondrial respiration assessed under hypoxic conditions might better represent the physiologic adaptations that occur after an exercise intervention. Diabetics were excluded because they differ in mitochondrial bioenergetics compared with nondiabetics and in relation to the degree of disease that would have been a confounding factor. 38 The mitochondrial response to exercise might therefore differ in diabetics.
CONCLUSIONS
Calf raise exercise improves walking performance. The training increases a biomarker of mitochondrial volume-density but not in mitochondrial respiration or maximal hyperemic response to ischemia. "Five plus" may be an easy, home-based, and efficient exercise training for patients with IC as an alternative to the usual advice to "stop smoking and keep walking." 
